{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:29:48Z","timestamp":1761823788770},"reference-count":21,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/mco.2016.786","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T08:48:44Z","timestamp":1456130924000},"page":"789-793","source":"Crossref","is-referenced-by-count":10,"title":["Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-\/very high-risk prostate cancer"],"prefix":"10.3892","volume":"4","author":[{"given":"SHINGO","family":"ASHIDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ICHIRO","family":"YAMASAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENJI","family":"TAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TSUTOMU","family":"SHIMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEIJI","family":"INOUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINJI","family":"KARIYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KANA","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUJI","family":"YAMAGAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TARO","family":"SHUIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"key20180107145735_b1-mco-0-0-786","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canrad.2011.01.004","article-title":"The role of brachytherapy in the definitive management of prostate cancer","volume":"15","author":"Crook","year":"2011","journal-title":"Cancer Radiother"},{"key":"key20180107145735_b2-mco-0-0-786","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.canrad.2012.08.001","article-title":"Role of high dose rate brachytherapy in the treatment of prostate cancer","volume":"16","author":"Ghilezan","year":"2012","journal-title":"Cancer Radiother"},{"key":"key20180107145735_b3-mco-0-0-786","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"key":"key20180107145735_b4-mco-0-0-786","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"key20180107145735_b5-mco-0-0-786","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2004.06.008","article-title":"European collaborative group on prostate brachytherapy: Preliminary report in 1175 patients","volume":"46","author":"Langley","year":"2004","journal-title":"Eur Urol"},{"key":"key20180107145735_b6-mco-0-0-786","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brachy.2009.04.007","article-title":"High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer","volume":"9","author":"Zwahlen","year":"2010","journal-title":"Brachytherapy"},{"key":"key20180107145735_b7-mco-0-0-786","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.brachy.2014.03.002","article-title":"High-dose-rate brachytherapy as monotherapy for prostate cancer","volume":"13","author":"Demanes","year":"2014","journal-title":"Brachytherapy"},{"key":"key20180107145735_b8-mco-0-0-786","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 2","key":"key20180107145735_b9-mco-0-0-786","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1007\/BF03038899","article-title":"Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer","volume":"175","author":"Kov\u00e1cs","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"key20180107145735_b10-mco-0-0-786","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(00)00687-8","article-title":"High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I\/II clinical trial","volume":"48","author":"Yoshioka","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b11-mco-0-0-786","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ijrobp.2011.05.001","article-title":"High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable\/intermediate-risk prostate cancer: Preliminary toxicity data","volume":"83","author":"Ghilezan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b12-mco-0-0-786","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.urology.2009.04.060","article-title":"Urinary side effects and complications after permanent prostate brachytherapy: The MD Anderson cancer center experience","volume":"74","author":"Anderson","year":"2009","journal-title":"Urology"},{"key":"key20180107145735_b13-mco-0-0-786","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125 iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"key20180107145735_b14-mco-0-0-786","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b15-mco-0-0-786","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.PPO.0000260917.97290.70","article-title":"Long-term rectal function after permanent prostate brachytherapy","volume":"13","author":"Merrick","year":"2007","journal-title":"Cancer J"},{"key":"key20180107145735_b16-mco-0-0-786","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b17-mco-0-0-786","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2012.07.004","article-title":"High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: Treatment evolution and mature results","volume":"85","author":"Zamboglou","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b18-mco-0-0-786","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2010.02.013","article-title":"Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions","volume":"80","author":"Yoshioka","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b19-mco-0-0-786","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(03)00081-6","article-title":"High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity","volume":"56","author":"Yoshioka","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145735_b20-mco-0-0-786","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society: American brachytherapy society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"key20180107145735_b21-mco-0-0-786","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2013.10.015","article-title":"Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial","volume":"110","author":"Yoshioka","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.786\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:57:46Z","timestamp":1515337066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,2,22]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/mco.2016.786"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.786","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}